In this study, since multiplex immunohistochemistry was technically difficult immediately after CD44-targeted NIR-PIT due to severe damage on tumor tissue that lead to ill-defined tumor boarder, we performed ex vivo CD44-targeted NIR-PIT on behalf. Here, CD44 is linked to neoplasm.